These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8610378)

  • 1. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis.
    Freeman RB; Tran S; Lee YM; Rohrer RJ; Kaplan MM
    Transplantation; 1996 Feb; 61(4):542-6. PubMed ID: 8610378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.
    Grassi A; Ballardini G
    World J Gastroenterol; 2014 Aug; 20(32):11095-115. PubMed ID: 25170198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares.
    Ciccorossi P; Filipponi F; Oliveri F; Campani D; Colombatto P; Bonino F; Campa M; Maltinti G; Mosca F; Brunetto MR
    J Viral Hepat; 2003 May; 10(3):168-73. PubMed ID: 12753334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological pattern of hepatitis C virus recurrence after liver transplantation.
    Rehermann B; Seifert U; Tillmann HL; Michel G; Böker KH; Pichlmayr R; Manns MP
    J Hepatol; 1996 Jan; 24(1):15-20. PubMed ID: 8834019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.
    Berenguer M; Prieto M; Córdoba J; Rayón JM; Carrasco D; Olaso V; San-Juan F; Gobernado M; Mir J; Berenguer J
    J Hepatol; 1998 May; 28(5):756-63. PubMed ID: 9625309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial.
    Singh N; Gayowski T; Wannstedt CF; Shakil AO; Wagener MM; Fung JJ; Marino IR
    Transplantation; 1998 Jan; 65(1):82-6. PubMed ID: 9448149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.
    Zervos XA; Weppler D; Fragulidis GP; Torres MB; Nery JR; Khan MF; Pinna AD; Kato T; Miller J; Reddy KR; Tzakis AG
    Transplantation; 1998 Apr; 65(8):1044-6. PubMed ID: 9583863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
    Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS
    Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
    Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantation.
    De Ruvo N; Cucchetti A; Lauro A; Masetti M; Cautero N; Di Benedetto F; Dazzi A; Del Gaudio M; Ravaioli M; Zanello M; La Barba G; di Francesco F; Risaliti A; Ramacciato G; Pinna AD
    Transplant Proc; 2005; 37(6):2607-8. PubMed ID: 16182760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation.
    Tisone G; Angelico M; Palmieri G; Pisani F; Anselmo A; Baiocchi L; Negrini S; Orlando G; Vennarecci G; Casciani CU
    Transplantation; 1999 May; 67(10):1308-13. PubMed ID: 10360582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatitis C virus RNA levels and histologic findings in liver allografts with early recurrent hepatitis C.
    Park YN; Boros P; Zhang DY; Sheiner P; Kim-Schluger L; Thung SN
    Arch Pathol Lab Med; 2000 Nov; 124(11):1623-7. PubMed ID: 11079013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.